Circulation Research, Vol 71, 3-8, Copyright © 1992 by American Heart Association

ARTICLES

Exclusion of cardiac myosin heavy chain and actin gene involvement in hypertrophic cardiomyopathy of several French families

K Schwartz, J Beckmann, C Dufour, L Faure, F Fougerousse, L Carrier, C Hengstenberg, D Cohen, HP Vosberg and A Sacrez
Institut National de la Sante et de la Recherche Medicale, Unite 127, Hopital Lariboisiere, Paris, France.

Familial hypertrophic cardiomyopathy (FHC) is characterized by idiopathic myocardial hypertrophy, which often and predominantly involves the interventricular septum. The disease is transmitted as an autosomal dominant trait, and its major risk is sudden death. It was recently demonstrated that this disease is genetically heterogeneous and that in 13 of 18 unrelated families the morbid locus, termed FHC-1, maps to chromosome 14q11-12 in and/or very near the cardiac beta-myosin heavy chain gene. We have performed linkage analysis with five chromosomal markers detecting polymorphisms in either the cardiac beta- myosin heavy chain gene or the cardiac actin gene (located on chromosome 15q) on eight families from different regions of France. We show that 1) it is possible to analyze medium-sized families by using highly informative microsatellite markers located in these genes and 2) the disease is not linked to the two contractile protein genes in any of these families. Moreover, 10-20% of chromosome 14 and 20-40% of chromosome 15 in the vicinity of the respective markers were excluded as possible locations for the morbid locus. These results provide new insights into the identification of the genes responsible for FHC.

This article has been cited by other articles:

				P. Jaaskelainen, M. Soranta, R. Miettinen, L. Saarinen, J. Pihlajamaki, K. Silvennoinen, T. Tikanoja, M. Laakso, and J. Kuusisto The cardiac {beta}-myosin heavy chain gene is not the predominant gene for hypertrophic cardiomyopathy in the Finnish population J. Am. Coll. Cardiol., November 15, 1998; 32(6): 1709 - 1716. [Abstract] [Full Text] [PDF]

				G. Bonne, L. Carrier, P. Richard, B. Hainque, and K. Schwartz Familial Hypertrophic Cardiomyopathy : From Mutations to Functional Defects Circ. Res., September 21, 1998; 83(6): 580 - 593. [Abstract] [Full Text] [PDF]

				M. Schafers, D. Dutka, C. G. Rhodes, A. A. Lammertsma, F. Hermansen, O. Schober, and P. G. Camici Myocardial Presynaptic and Postsynaptic Autonomic Dysfunction in Hypertrophic Cardiomyopathy Circ. Res., January 23, 1998; 82(1): 57 - 62. [Abstract] [Full Text] [PDF]

				A.J. Marian and R. Roberts Recent Advances in the Molecular Genetics of Hypertrophic Cardiomyopathy Circulation, September 1, 1995; 92(5): 1336 - 1347. [Full Text]

				K. Schwartz, L. Carrier, P. Guicheney, and M. Komajda Molecular Basis of Familial Cardiomyopathies Circulation, January 15, 1995; 91(2): 532 - 540. [Full Text]

				D. P. Kelly and A. W. Strauss Inherited Cardiomyopathies N. Engl. J. Med., March 31, 1994; 330(13): 913 - 919. [Full Text]